Changing paradigms in cutaneous immunology: Adapting with dendritic cells

Journal of Investigative Dermatology

Volumn 124, Issue 1, 2005, Pages 1-12

  Larregina, Adrians T ^a   Falo Jr , Louis D ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALPHA 1 ANTITRYPSIN; ALPHA INTERMEDIN; BLOOD CLOTTING FACTOR 13A; CANCER GROWTH FACTOR; CD1 ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD19 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD45RO ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CHYMOTRYPSIN; CORTICOTROPIN; HAPTEN; HEMOSIDERIN; INTERLEUKIN 10; INTERLEUKIN 12; MELANIN; MICROSOMAL AMINOPEPTIDASE; NEUROPEPTIDE; PEPTIDE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TRYPSIN; UVOMORULIN;

ACIDIFICATION; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ATOPIC DERMATITIS; BIOSENSOR; BONE MARROW TRANSPLANTATION; CELL ACTIVATION; CELL ADHESION; CELL CLONE; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL INTERACTION; CELL MEMBRANE; CELL MIGRATION; CELL STRUCTURE; CELL SURFACE; CELL TRANSPORT; CELL TYPE; CELL WALL; CELLULAR IMMUNITY; CONNECTIVE TISSUE; CONTACT SENSITIZATION; CROSS PRESENTATION; CROSS TOLERANCE; CYTOTOXICITY; DENDRITIC CELL; DERMIS; ENDOSOME; ENDOTHELIUM CELL; EPIDERMIS; EPITHELIUM CELL; FIBROBLAST; HERPES SIMPLEX VIRUS 2; HISTIOCYTE; HISTIOCYTOMA; HISTIOCYTOSIS X; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; HYPERSENSITIVITY REACTION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOSTIMULATION; KELOID; KERATINOCYTE; LANGERHANS CELL; LEISHMANIA; LEUKOCYTE; LYMPH NODE; LYMPHOID ORGAN; LYSOSOME; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOCYTE; MELANOMA; MONOCYTE; MONONUCLEAR PHAGOCYTE; MOUSE; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL CIRCULATION; PHAGOCYTOSIS; PHENOTYPE; PLASTICITY; PRIORITY JOURNAL; PURIFICATION; REVIEW; SKIN; SKIN INFLAMMATION; SKIN TUMOR; SPLEEN; STEADY STATE; STRESS; T LYMPHOCYTE; TUMOR CELL; ULTRAVIOLET B RADIATION; X RAY;

EID: 11944249877     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1747.2004.23554.x     Document Type: Review

References (122)

1. Akbari O, Panwani N, Garcia S, Tascon R, Lowrie D, Stockinger B: DNA transfection and activation of dendritic cells as a key events for immunity. J Exp Med. 189: 169-177, 1999
2. Albert ML, Sauter B, and Bhardwaj N: Dendritic cells acquire antigens from apoptotic cells and induce class I restricted CTLs. Nature. 392: 86-89, 1998
3. Anjuere F, Martinez del Hoyo G, Martin P, Ardavin C: Langerhans cells acquire a CD8+ dendritic cell phenotype on maturation by CD40 ligation. J Leukoc Biol 67: 206-209, 2000
4. Allan RS, Smith CM, Belz GT, van Lint AL, Wakim LM, Heath WR, Carbone FR: Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science 301: 1925-1928, 2003
5. Ardavin C: Origin, precursors and differentiation of mouse dendritic cells. Nat Rev Immunol 3: 582-590, 2003
6. Arstein SB: Acad Wiss. Math Nat KI 74: 203, 1876
7. Bhardwaj JM, Schwarz A, Becher E, et al Pro-opiomelanocortina-derived peptides induce IL-10 production in human monocytes. J Immunol 156: 2517-2521, 1996
8. Baldwin T, Henri S, Curtis J, O'Keeffe M, Vremec D, Shortman K, Handman E: Dendritic cell populations in Leishmania major-infected skin and draining lymph nodes. Infect Immun 72: 1991-2001, 2004
9. Banchereau J, Steinman RM: Dendritic cells and the control of the immunity. Nature 392, 245-252, 1998.
10. Bardan A. Nizet V. and Gallo RL.: Antimicrobial peptides and the skin. Expert Opinion on Biological Therapy. 4(4): 543-9, 2004.
11. Bohm M, Luger TA: The pilosebaceous unit is a part of the skin immune system. Dermatolog. 196: 75-79, 1998.
12. Borkowski TA, Letterio JJ, Farr AG, Udey MC: A role of endogenous Transforming growth factor β1 in Langerhans cell biology: the skin of Transforming growth factor β1 null mice is devoid of epidermal Langerhans cells. J Exp Med 184: 2417-2422, 1996
13. Brigl M, Brenner MB: CD1: antigen presentation and T cell function. Ann Rev Immunol 22: 817-890, 2004
14. Brossay L, Chioda M, Burdin N, Koezuka Y, Casorati G, Dellabona P, Kronenberg M. CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med 188: 1521-1528, 1998
15. Cella M, Facchetti F, Lanzavecchia A, Colonna M: Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1polarization. Nat Immunol 1: 305-310, 2000
16. Celluzzi, CM, Mayordomo, JI, Storkus WJ, Lotze MT, and Falo, LD, Jr.: Peptide-pulsed dendritic cells induce antigen specific CTL-mediated protective tumor immunity. J. Exp. Med., 183(1): 283-287, 1996.
17. Celluzzi CM, Falo Jr. LD. Epidermal dendritic cells induce potent antigen -specific CTL- mediated immunity. J. Invest. Dermatol. 108: 716-720, 1997
18. Celluzzi CM, Falo Jr. LD: Physical interaction between dendritic cells and tumor cells results in in an immunogen that induces protective and therapeutic tumor rejection. J Immunol. 160: 3081-3085, 1998
19. Cerio R, Griffiths CE, Cooper KD, Nicoloff BJ, Headington JT: Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br J Dermathol 121: 421-431, 1989.
20. Charbonnier AS, Kohrgruber N, Kriehuber E, Stingl G, Rot A, Maurer D: Macrophage inflammatory protein 3 alpha is involved in the constitutive trafficking of epidermal Langerhans cells. J Exp Med 190: 1755-1768 1999.
21. Cho JH, Youn JW, Sung YC: Cross-priming as a predominant mechanism for inducing CD8(+) T cell responses in gene gun DNA immunization. J Immunol 167: 5549-5557, 2001
22. Condon C, Watkins SC, Celluzzi CM, Thompson K, Falo Jr. LD: DNA-based imunization by in vivo transfection of dendritic cells. Nature Med. 2: 1122-1128, 1996.
23. Cumberbach M, Fielding I, Kimber I: Modulation of epidermal Langerhans cell frequency by tumor necrosis factor α. Immunology. 81: 395-401, 1994
24. Cumberbach M, Kimber I: Tumor necrosis factor-a is required for the accumulation of dendritic cells in drainning lymph nodes after contact sensitization. Immunology. 84: 31-35, 1995
25. Cumberbach M, Dearman RJ, Kimber I: Langerhans cells require signals from both tumor necrosis factor a and IL-1b for migration. Immunology. 92: 388-395, 1997
26. del Hoyo GM, Martin P, Vargas HH, Ruiz S, Arias CF, Ardavin C: Characterization of a common precursor population for dendritic cells. Nature 415: 1043-1047, 2002
27. Dezutter-Dambuyant C, Cordier G, Schmitt, D, Faure M., Laquoi C, and Thivolet J: Quantitative evaluation of two distinct cell populations expressing HLA-DR antigens in normal human epidermis. Br J Dermatol III: 1-11, 1984
28. Ebner S, Ehammer Z, Holzmann S, et al Expression of C-type lectin receptors by subsets of dendritic cells in human skin. Int Immunol 16: 877-887, 2004
29. Enk AH, Angeloni VL, Udey MC, Katz SI: An essential role for Langerhans derived IL-1β in the initiation of primary immune responses in the skin. J Immunol. 150, 3698-3704, 1993.
30. Enk AH, Jonuleit H, Saloga J, Knop J: Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int J Cancer 73: 309-316, 1997
31. Exley M, Garcia J, Balk SP, Porcelli S: Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells. J Exp Med 186: 109-120, 1997
32. Falo Jr LD, Kovacsovics-Bankowski, M Thompson K, Rock, KL. Targeting antigen into the phagocytic pathway in vivo induces protective tumor immunity. Nature Med. 1: 649-653, 1995
33. Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL: Plasmacytoid dendritic cells (natural Interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol 159: 237-243, 2001
34. Geissmann F, Prost C, Monnet JP, Dy M, Brousse N, Hermine O: Transforming growth factor [beta] 1, in the presence of Granulocyte/Macrophage Colony Stimulating Factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med 187: 961-966, 1998
35. Geissmann F, Dieu-Nosjean MC, Dezutter C: Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J Exp Med 196: 417-430, 2002
36. Grabbe S, Steinbrink K, Steinert M, Luger TA, Schwarz T: Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. J Immunol 155: 4207-4217, 1995
37. Grabbe S, Bhardwaj RS, Mahnke K, Simon MM, Schwarz T, Luger TA: Alpha melanocyte stimulating hormone induces hapten -specific tolerance in mice. J. Immunol. 156: 473-478, 1996
38. + T cell subset inhibits antigen specific T-cell responses and prevents colitis. Nature 389: 737-742, 1997
39. Harshyne LA., Watkins SC., Gambotto A., and Barratt-Boyes SM: Dendritic cells acquire antigens from live cells for cross-presentation to CTL. Journal of Immunology. 166: 3717-3723, 2001.
40. Headington JT: The dermal dendrocyte. Advan Dermatol. Callen JP, Dahl HV, Golitz LE, Rasmussen, JE, and Dtregman ST editors. Yearbook. Medical Publishers. Chicago.IL. USA. pp:159-170, 1986
41. Headington JT: Dermal dendrocytes. In: Dermal immune system. Nickoloff BJ editor. CRC Press. Boca Raton. FL.USA. Chapter2: 1-6, 1993
42. Heath WR, Carbone FR:Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 19: 47-64, 2001
43. Heath WR, Belz GT, Behrens GM, et al: Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 199: 9-26, 2004
44. Hemmi H, Yoshino M, Yamazaki H:Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-beta1-dependent cells. Int Immunol 13: 695-704, 2001
45. Herxeimer K: Uber pemphigus vegetans nebst bermerkungen uber die natur der Langerhans zellen. Arch. Derm. Syph 36: 140, 1896
46. Holt PG, Haining S, Nelson DJ, Sedwick JD: Origin and steady-state turnover of Classll MHC-bearing dendritic cells in the epithelium of the conducting airways. J Immunol 153: 256-261, 1994
47. Holzman S, Tripp CH, Schmuth M et al. A model system using tape striping for characterization of Langerhans cell precursors in vivo. J Invest Derm 122: 1165-1174, 2004
48. Hosoi J, Murphy GF, Egan CL, Lerner EA, Grabbe S, Asashina S, Granstein RD. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 363: 159-163, 1993
49. Hunger RE, Sieling PA, Ochoa MT et al: Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. J Clin Invest 113: 701-708 2004
50. Jakob T, Ring J, Udey CM: Multistep navigation of Langerhans/dendritic cells in and out of the skin. J Allergy Clin Immunol 108: 688-696, 2001
51. Jonuleit H. and Schmitt E.: The regulatory T cell family: distinct subsets and their interrelations. Journal of Immunology. 171: 6323-6327, 2003.
52. Kang, K., Hammerberg, C., Meunier, L. Cooper, K.D. CD11b+ macrophages that infiltrate human epidermis after in vivo ultraviolet exposure potently produce IL-10 and represent the major secretory source of epidermal IL-10 protein. J. Immunol. 153: 5256-5264, 1994
53. Katz SL, Tamaki T, Sachs D: Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 282: 324-326, 1979
54. Kovacsovics-Bankowski M, Rock K: A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267: 243-246, 1995
55. Kronin V, Winkel K, Suss G, Kelso A, Heath W, Kirberg J, von Boehmer H, Shortman K: A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production. J Immunol. 157: 3819-3827, 1996
56. Krueger GG, Daynes RA, Emam M: Biology of Langerhans cells: Selective migration of Langerhans cells into allogeneic and xenogeneic grafts on nude mice. Proc Natl Acad Sci USA 80: 1650-1654, 1983
57. Krueger GG, Emam M: Biology of Langerhans cells: Analysis by experiments to deplete Langerhans cells from human skin. J Invest Derm 82: 613-617, 1984
58. Kupper TS. and Fuhlbrigge RC. Immune surveillance in the skin: mechanisms and clinical consequences. Nature Reviews. Immunology. 4: 211-222, 2004
59. Langerhans P: Uber die nerven der menschilen haut. Virch. Arch. (Pathol Anat) 44: 325-237, 1868
60. Larregina AT, and Falo Jr. LD: Generating and regulating immune responses through cutaneous gene delivery. Hum. Gene Ther. 11: 2301-2305, 2000
61. Larregina, AT, Watkins SC, Erdos G, Spencer LA, Storkus WJ, Beer Stolz D, Falo Jr. LD: Direct transfection and activation of human cutaneous dendritic cells. Gene Ther. 8: 608-617, 2001a
62. Larregina AT, Falo Jr. LD: Dendritic cells in the context of skin immunity. In: Dendritic Cell Biology and Clinical Applications. Lotze M and Thomson AW editors. Accademic Press. London. UK. Chapter 23: 301-314, 2001b
63. Larregina AT, Morelli AE, Spencer LA, Logar AJ, Watkins SC, Thomson AW, Falo LD Jr: Dermal-resident CD14+ cells differentiate into Langerhans cells. Nature Immunol 2: 1151-1158, 2001c
64. Larsen CP, Steinman R M, Witmer Pack M, Hankins DF, Morris PJ, Austyn JM: Migration and maturation of Langerhans cells in skin transplants and explants. J. Exp. Med 172: 1483-1493, 1990
65. Lenz A, Heine G, Schuler G, and Romani J. (1993). Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J Clin Invest 92, 2587-2596.
66. Lucas A, MacPherson G: Langerhs cells: immigrants or residents. Nat Immunol 3: 1125-1126, 2002
67. Maurer Dieter, Stingl G: Langerhans cells. In: Dendritic Cell Biology and Clinical Applications. Lotze M and Thomson AW editors. Accademic Press. London. UK. Chapters: 301-314, 2001
68. Mc Dermott R, Ziylan U, Spehner D et al. Birbeck granules are subdomains of endosomal recycling compartment in human epidermal Langerhans cells, which form where Langerin accumulates. Mol Biol Cell 2002 13: 317-335, 2002
69. Merad M, Manz M, Karunsky H et al. Langerhans cells renewe in the skin throughout life under steady state conditions. Nature Immunol 3: 1135-1141, 2002
70. Meunier L, Bata-Csorgo Z, Cooper KD: In human dermis, ultraviolet radiation induces expansion of a CD36+CD11b+CD1- macrophage subset by infiltration and proliferation; CD1+ Langerhans-like dendritic antigen-presenting cells are concomitantly depleted. J. Invest. Dermatol 105: 782-788, 1995.
71. Mishima Y: Melanosomes in phagocytic vacuoles in Langerhans cells. Electron microscopy of keratin-stripped human epidermis. J Cell Biol 30: 417-423, 1966
72. Mizumoto N, Kumamoto T, Robson SC, Sevigny J, Matsue H, Enjyoji K, Takashima A: CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nature Med 8: 358-365, 2002
73. Mizumoto N, Mummert ME, Shalhevet D, Takashima A: Keratinocyte ATP release assay for testing skin-irritating potentials of structurally diverse chemicals. J Invest Dermatol. 121: 1066-1072, 2003
74. Mizumoto N, Takashima A: CD1a and langerin: acting as more than Langerhans cell markers. J Clin Invest 113: 658-660, 2004
75. Morelli A, Kolkowski E, Larregina A, Sanjuan N, Fainboin L: Phenotype of Langerhans cells during maturation to veiled cells. In: Schlossman, SF Boumsell, L Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder, TF, and Todd RF editors. Leukocyte Typing V. Wite Cell Differentiation Antigens. Oxford University Press, New York USA.: 1064-1066, 1995
76. Morelli A, Larregina A, Chuluyan E, Kolkowsky E, Fainboim L. Expression and modulation of C5a receptor (CD88) on skin dendritic cells. Chemotatic effect of the C5a on skin migratory dendritic cells. Immunology 89: 126-134, 1996
77. Morelli AE. Hackstein H, Thomson AW: Potential tolerogenic dendritic cells for transplantation. Sem Immunol 13: 323-335, 2001
78. Morelli AE, Larregina AT, Shufesky WJ et al: Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 101: 611-620, 2003
79. Moschella SL, Cropley TG: Mononuclear phagocytic and dendritic cell systems. J Amer Acad Derm 22: 1091-1097, 1990
80. Murphy GF, Messadi D, Fonferko E, Hancock WW: Phenotypic transformation of macrophages to Langerhans cells in the skin. Am J Pathol. 123: 401-406, 1986.
81. Nestle FO, Zheng XG, Thompson CB, Turka LA, Nickoloff BJ: Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functional distinctive subsets. J Immunol 151: 6535-6445, 1993
82. Nestle O, Nickoloff BJ: A fresh morphological and functional look at dermal dendritic cells. J Cut Pathol 22: 385-393, 1995
83. Nestle FO, Filgueira L, Nickoloff BJ, Burg G: Human dermal dendritic cells process and present soluble protein antigens. J Invest Dermatol 110: 762-766; 1998
84. Nickoloff BJ, Wrone-Smith T, Bonish B, Porcelli SA: Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161. Arch Dermatol. 135: 546-552, 1999
85. Nickoloff BJ: Cutaneous dendritic cells in the crossfire between innate and adaptive immunity. J Derm Sci 29: 159-165, 2002
86. Niizeki H, and Streiling JW: Hapten-specific tolerance induced by acute, low dose ultraviolet B radiation of skin is mediated via interleukin-10. J. Invest. Dermatol. 109, 25-30, 1997.
87. Novak N, Valenta R, Bohle B, Laffer S, Haberstok J, Kraft S, Bieber T: FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro. J Allergy Clin Immunol 113: 949-957, 2004
88. O'Garra A and Vieira P.: Regulatory T-cells and mechanisms of immune system control. Nature Medicine. 10 801-805, 2004.
89. Oppenheim JJ, Biragyn A, Kwak LW, and Yang D.: Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Annals of the Rheumatic Diseases. 62 Suppl 2: ii17-21, 2003.
90. Parr MB, Kepple L, Parr EL: Langerhans cells phagocytose vaginal epithelial cells undergoing apoptosis during the murine estrous cycle. Biol Reprod 45: 252-260, 1991
91. Pena-Cruz V, Ito S, Dascher CC, Brenner MB, Sugita M: Epidermal Langerhans cells efficiently mediate CD1a-dependent presentation of microbial lipid antigens to T cells. J Invest Dermatol. 121: 517-521, 2003
92. Pizak J, Holikova Z, Dvorankova B, et al: Analysis of binding of mannosides in relation to Langerin (CD207) in Langerhans cells of normal and transformed epithelia. Histochem J 34: 247-253 2002
93. Porcelli SA. Modlin RL. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annual Review of Immunology. 17: 297-329, 1999.
94. Porgador A, Irvine KJ, Iwasaki A, Barber BH, Restifo N, Germain RN: Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. J Exp Med. 188: 1075-1082, 1998.
95. Romani N, Schuler G, Fritsch P: Identification and phenotype of epidermal Langerhans cells. In Epidermal Langerhans cells. Schuler G Editor. CRC Press. Inc. Boca Raton. FL. USA. Chapter 3: 49-86, 1991.
96. Sandrine H, Vremec D, Kamath A et al: The dendritic cell populations of mouse lymph nodes. J Immunol 167: 741-748, 2001
97. Santiago-Schwarz, F., Belilos, E., Diamond, B. and Carsons, S.E. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J. Leukoc. Biol. 52: 274-281 (1992).
98. Schwarzenberger K, Udey MC: Contact allergens and epidermal proinflamatory cytokines modulate Langerhans cell E-cadherin expression in situ. J. Invest. Dermatol. 106: 553-558, 1996
99. Schawer E, Trauntinger F, Koch A, et al: Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. J Clin Invest. 93: 2258-2262, 1994
100. Shen L, Sigal LJ, Boes M, Rock KL: Important Role of Cathepsin S in Generating Peptides for TAP-Independent MHC Class I Crosspresentation In Vivo. Immunity 21: 155-165, 2004
101. Silverberg I, Baer RL, Rosenthal SA: The role of Langerhans cells in allergic contact hypersensitivity. A review of findings in man and guinea pigs. J Invest Dermatol 66: 210-217, 1976
102. Spada FM, Koezuka Y, Porcelli SA: CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med. 188: 1529-1534, 1998
103. Steinman RM, Cohn ZA: Identification of a novel cell type in peripheral lymphoid organs of mice. Morphology, quantitation and distribution. J Exp Med 137: 1142-1162, 1973
104. Steinman RM: The dendritic cell system and its role in immunogenicity. Ann Rev Immunol 9: 271-296, 1991
105. Steinman RM, Hawiger D, Nussenzweig MC: Tolerogenic dendritic cells. Annu Rev Immunol. 2: 685-711, 2003
106. + hematopoietic progenitors. J. Immunol. 157: 1499-1507, 1996
107. Suss G, Shortman K: A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J Exp Med. 183: 1789-1796, 1996
108. Suvarna SK, Cotton DWK: Dermal dendrocytes and other factor XIII-positive cells. J of Pathol 171: 251-252, 1993
109. Tang A, Amagani M, Granger LG, Stanley JR, Udey MC: Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature: 361: 82-85, 1993.
110. Teunissen MBM, Kapsemberg ML, Bos JD: Langerhans cells and related skin dendritic cells. In Skin Immune system (SIS). 2nd Edition. Bos JD editor. CRC Press. Raton. FL. USA Chapter 5: 59-83, 1997
111. Traver D, Akashi K, Manz M, Merad M, Miyamoto T, Engleman EG, Weissman IL: Development of CD8alpha-positive dendritic cells from a common myeloid progenitor. Science. 290: 2152-2154, 2000
112. Valladeau J, Ravel O, Dezutter-Dambuyant C: Langerin, a novel c-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12: 71-81, 2000
113. Valladeau J, Clair-Moninot V, Dezutter-Dambuyant C, et al. Identification of mouse langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissues. J Immunol 168: 782-792, 2002
114. Watts C: The exogenous pathway for antigen presentation on major hystocompatibility complex class II and CD1 molecules. Nat Immunol 5: 685-692, 2004
115. Wolff K: The fascinating story that began in 1868. In: Epidermal Langerhans Cells. CRC Press, Boca Raton. FL. Chapter 1: 1-22, 1991
116. Wollenberg A, Kraft S, Hanau D, Bieber T: Immunomorphological and untrastructural characterization of Langerhans cells and a novel inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Derm 106: 446-453, 1996
117. Wollenberg A, Haberstok J, Teichmann B, Wen SP, Bieber T: Demonstration of the low-affinity IgE receptor Fc epsilonRII/CD23 in psoriatic epidermis: inflammatory dendritic epidermal cells (IDEC) but not Langerhans cells are the relevant CD1a-positive cell population. Arch Dermatol Res 290: 517-521, 1998
118. Wollenberg A, Wagner M, Gunther S, et al: Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J Invest Dermatol 119: 1096-1102, 2002
119. Yoshino M, Yamazaki H, Nakano H, Kakiuchi T, Ryoke K, Kunisada T, Hayashi S: Distinct antigen trafficking from skin in the steady and active states. Int Immunol 15: 773-779, 2003
120. Yedwell JW, Bennik JR: Cell biology of antigen processing and presentation to MHC class I molecule restricted T lymphocytes. Adv. Immunol 52: 1-42, 1992
121. York IA, Rock KL: Antigen processing and presentation by class I major histocompatibility complex. Ann. Rev. Immunol 14: 369-396, 1996
122. Zhao X, Deak E, Soderberg K, Linehan M, Spezzano D, Zhu J, Knipe DM, Iwasaki A: Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses, J. Exp MED 197: 153-162, 2003